NIH funding UIC brain tumor research

May 08, 2007

Researchers at the University of Illinois at Chicago College of Pharmacy have received a $1.7 million five-year federal grant to develop a new approach to treat brain tumors.

A hydrogel-based delivery system, similar in consistency to gelatin, has been developed to control the release of chemotherapy drugs that will kill glioblastoma multiforme, the most advanced and invasive form of brain tumor, and other solid tumors, said Richard Gemeinhart, assistant professor in the departments of biopharmaceutical sciences and bioengineering and lead researcher of the study. The novel approach stabilizes the drug and provides better control of the time and location of its activity, thereby reducing its side effects.

Gemeinhart said the drug will be activated from the hydrogel through the overactivity of matrix metalloproteases, enzymes that renew extracellular matrix in tissue that include the joints.

Approximately 40,000 people are diagnosed each year with a new brain tumor, according to the National Institutes of Health. Of these new tumors, 50 percent are primary and 50 percent have originated in other parts of the body and traveled to the brain.

Brain tumors are the third leading cause of death from cancer in individuals ages 20 to 39; about 13,000 people die of malignant brain tumors each year in the United States. About 1,500 children in the U.S. are diagnosed with a brain tumor each year.

Surgery followed by chemotherapy is the primary treatment for glioblastoma multiforme, Gemeinhart said. However, surgery alone cannot completely treat the disease or prevent its recurrence. The chemotherapy drugs currently used are limited due to systemic toxicity, resistance, and their inability to efficiently cross the blood brain barrier, he said.

"Our understanding of the disease suggests that localizing chemotherapy to the tumor resection site can improve survival," Gemeinhart said. "Currently, the mean survival time for glioblastoma multiforme patients is one year."

All of the work to date has been performed in vitro, Gemeinhart said, but preclinical models are planned as part of the grant.
-end-
The grant is funded by the National Institute of Neurological Disorders and Stroke, one of the National Institutes of Health.

For more information about UIC, visit www.uic.edu.

University of Illinois at Chicago

Related Chemotherapy Articles from Brightsurf:

Chemotherapy is used to treat less than 25% of people with localized sarcoma
UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.

Starved cancer cells became more sensitive to chemotherapy
By preventing sugar uptake, researchers succeeded in increasing the cancer cells' sensitivity to chemotherapeutic treatment.

Vitamin D could help mitigate chemotherapy side effects
New findings by University of South Australia researchers reveal that Vitamin D could potentially mitigate chemotherapy-induced gastrointestinal mucositis and provide relief to cancer patients.

Less chemotherapy may have more benefit in rectal cancer
GI Cancers Symposium: Colorado study of 48 patients with locally advanced rectal cancer receiving neoadjuvant chemotherapy, found that patients receiving lower-than-recommended doses in fact saw their tumors shrink more than patients receiving the full dose.

Male fertility after chemotherapy: New questions raised
Professor Delb├Ęs, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma.

'Combo' nanoplatforms for chemotherapy
In a paper to be published in the forthcoming issue in NANO, researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging.

Nanotechnology improves chemotherapy delivery
Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients' treatments within the crucial therapeutic window.

Novel anti-cancer nanomedicine for efficient chemotherapy
Researchers have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

Ending needless chemotherapy for breast cancer
A diagnostic test developed at The University of Queensland might soon determine if a breast cancer patient requires chemotherapy or would receive no benefit from this gruelling treatment.

A homing beacon for chemotherapy drugs
Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.

Read More: Chemotherapy News and Chemotherapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.